References
[1] M. L. Danielson et al., “ADHD Prevalence Among U.S. Children and Adolescents in 2022: Diagnosis, Severity, Co-Occurring Disorders, and Treatment,” J. Clin. Child Adolesc. Psychol. Off. J. Soc. Clin. Child Adolesc. Psychol. Am. Psychol. Assoc. Div. 53, vol. 53, no. 3, pp. 343–360, 2024, doi: 10.1080/15374416.2024.2335625.
[2] T. E. Wilens, J. Biederman, S. V. Faraone, M. Martelon, D. Westerberg, and T. J. Spencer, “Presenting ADHD Symptoms, Subtypes, and Comorbid Disorders in Clinically Referred Adults with ADHD,” J. Clin. Psychiatry, vol. 70, no. 11, p. 1557, Nov. 2009, doi: 10.4088/JCP.08m04785pur.
[3] P. De Rossi, I. Pretelli, D. Menghini, B. D’Aiello, S. Di Vara, and S. Vicari, “Gender-Related Clinical Characteristics in Children and Adolescents with ADHD,” J. Clin. Med., vol. 11, no. 2, p. 385, Jan. 2022, doi: 10.3390/jcm11020385.
[4] R. Drechsler, S. Brem, D. Brandeis, E. Grünblatt, G. Berger, and S. Walitza, “ADHD: Current Concepts and Treatments in Children and Adolescents,” Neuropediatrics, vol. 51, no. 5, pp. 315–335, Oct. 2020, doi: 10.1055/s-0040-1701658.
[5] D. Gkougka et al., “Gut microbiome and attention deficit/hyperactivity disorder: a systematic review,” Pediatr. Res., vol. 92, no. 6, pp. 1507–1519, Dec. 2022, doi: 10.1038/s41390-022-02027-6.
[6] E. Aarts et al., “Gut microbiome in ADHD and its relation to neural reward anticipation,” PLoS ONE, vol. 12, no. 9, p. e0183509, Sep. 2017, doi: 10.1371/journal.pone.0183509.
[7] J. F. Cryan and T. G. Dinan, “Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour,” Nat. Rev. Neurosci., vol. 13, no. 10, pp. 701–712, Oct. 2012, doi: 10.1038/nrn3346.
[8] J. P.-C. Chang, K.-P. Su, V. Mondelli, and C. M. Pariante, “Omega-3 Polyunsaturated Fatty Acids in Youths with Attention Deficit Hyperactivity Disorder: a Systematic Review and Meta-Analysis of Clinical Trials and Biological Studies,” Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol., vol. 43, no. 3, pp. 534–545, Feb. 2018, doi: 10.1038/npp.2017.160.
[9] Z. Darabi, A. A. Vasmehjani, M. Darand, A. A. Sangouni, and M. Hosseinzadeh, “Adherence to Mediterranean diet and attention-deficit/hyperactivity disorder in children: A case control study,” Clin. Nutr. ESPEN, vol. 47, pp. 346–350, Feb. 2022, doi: 10.1016/j.clnesp.2021.11.014.
[10] J. T. Nigg, K. Lewis, T. Edinger, and M. Falk, “Meta-analysis of attention-deficit/hyperactivity disorder or attention-deficit/hyperactivity disorder symptoms, restriction diet, and synthetic food color additives,” J. Am. Acad. Child Adolesc. Psychiatry, vol. 51, no. 1, pp. 86-97.e8, Jan. 2012, doi: 10.1016/j.jaac.2011.10.015.
[11] K. van der Horst, A. Ferrage, and A. Rytz, “Involving children in meal preparation. Effects on food intake,” Appetite, vol. 79, pp. 18–24, Aug. 2014, doi: 10.1016/j.appet.2014.03.030.
[12] M. Barone, F. D’Amico, P. Brigidi, and S. Turroni, “Gut microbiome-micronutrient interaction: The key to controlling the bioavailability of minerals and vitamins?,” BioFactors Oxf. Engl., vol. 48, no. 2, pp. 307–314, Mar. 2022, doi: 10.1002/biof.1835.
[13] A. Pärtty, M. Kalliomäki, P. Wacklin, S. Salminen, and E. Isolauri, “A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial,” Pediatr. Res., vol. 77, no. 6, pp. 823–828, Jun. 2015, doi: 10.1038/pr.2015.51.
[14] P. A, M. Tk, M. D, and D. B, “Human Gut Microbiota and Drug Metabolism,” Microb. Ecol., vol. 86, no. 1, Jul. 2023, doi: 10.1007/s00248-022-02081-x.
[15] Z. F et al., “Bioavailability Based on the Gut Microbiota: a New Perspective,” Microbiol. Mol. Biol. Rev. MMBR, vol. 84, no. 2, Apr. 2020, doi: 10.1128/MMBR.00072-19.
[16] J. Aresti-Sanz, M. Schwalbe, R. R. Pereira, H. Permentier, and S. El Aidy, “Stability of Methylphenidate under Various pH Conditions in the Presence or Absence of Gut Microbiota,” Pharm. Basel Switz., vol. 14, no. 8, p. 733, Jul. 2021, doi: 10.3390/ph14080733.
[17] K. Hn, R. S, S. A, and B. V, “Emerging Role and Place of Probiotics in the Management of Pediatric Neurodevelopmental Disorders,” Euroasian J. Hepato-Gastroenterol., vol. 12, no. 2, Dec. 2022, doi: 10.5005/jp-journals-10018-1384.
[18] S. E et al., “Effects of Probiotic Supplementation on Gastrointestinal, Sensory and Core Symptoms in Autism Spectrum Disorders: A Randomized Controlled Trial,” Front. Psychiatry, vol. 11, Sep. 2020, doi: 10.3389/fpsyt.2020.550593.
[19] O. Jadrešin, S. Sila, I. Trivić, Z. Mišak, S. Kolaček, and I. Hojsak, “Lactobacillus reuteri DSM 17938 is effective in the treatment of functional abdominal pain in children: Results of the double-blind randomized study,” Clin. Nutr. Edinb. Scotl., vol. 39, no. 12, pp. 3645–3651, Dec. 2020, doi: 10.1016/j.clnu.2020.04.019.
[20] L.-J. Wang, C.-Y. Yang, H.-C. Kuo, W.-J. Chou, C.-S. Tsai, and S.-Y. Lee, “Effect of Bifidobacterium bifidum on Clinical Characteristics and Gut Microbiota in Attention-Deficit/Hyperactivity Disorder,” J. Pers. Med., vol. 12, no. 2, p. 227, Feb. 2022, doi: 10.3390/jpm12020227.